EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer
Article in Cancers (April 2024)
The most recent citing publications are shown below. View all 54 publications that cite this research output on Dimensions.
Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of Lovastatin
Article in International Journal of Biological Sciences (March 2024)
Identification and Validation of a Prognostic Signature Derived from the Cancer Stem Cells for Oral Squamous Cell Carcinoma
Article in International Journal of Molecular Sciences (January 2024)